Literature DB >> 31449930

Peptide-immobilized starch/PEG sponge with rapid shape recovery and dual-function for both uncontrolled and noncompressible hemorrhage.

Xiao Yang1, Wen Liu2, Yifen Shi3, Guanghui Xi2, Mingshan Wang3, Bin Liang3, Yakai Feng4, Xiangkui Ren5, Changcan Shi6.   

Abstract

It is challenging for traditional hemostatic sponges to meet the clinic demand for both uncontrolled and noncompressible hemorrhage. With the aim to develop a rapid shape recovery material with both active and passive hemostatic performance, a dual-functional hemostatic sponge (TRAP-Sp) with a macroporous structure and good mechanical properties for controlling massive and noncompressible hemorrhage was prepared by chemically immobilizing thrombin-receptor-agonist-peptide (TRAP) onto a starch/polyethylene glycol (PEG) sponge. The TRAP2-Sp1 showed the best hemostatic performance among all samples in both rat artery uncontrollable hemorrhage and liver defect noncompressible hemorrhage models. When analyzing the hemostatic mechanism of TRAP-Sp, the high water absorption capacity of the sponge contributed to absorbing plasma, concentrating blood cells, and enhancing blood coagulation. After absorbing water, the shape-fixed TRAP-Sp with sufficient mechanical strength and high resilience can rapidly expand and apply pressure to the wound. TRAP immobilized on the sponge could activate the adhered platelets in an active pathway. Additionally, evaluation of cytotoxicity, hemolysis, and histology further highlighted the adequate biocompatibility of TRAP-Sp. With excellent hemostatic performance and biosafety, this sponge could be a potential candidate as a topical hemostatic agent for uncontrolled and noncompressible hemorrhage. STATEMENT OF SIGNIFICANCE: There is a need for innovative hemostatic materials for both uncontrolled and noncompressible hemorrhage. This manuscript describes a rapid shape recovery hemostatic sponge with both active and passive hemostatic performances synthesized by foaming technique, cross-linking reaction, and chemical immobilization of thrombin-receptor-agonist-peptide (TRAP). On contact with blood, the shape-fixed sponge can not only rapidly recover its original shape and concentrate platelets and RBCs but also activate the adhered platelets efficiently. The dual-functional sponge has excellent hemostatic efficacy in rat femoral artery hemorrhage and can control noncompressible hemorrhage in penetrating liver wound. Thus, we believe that this sponge could be a potential candidate as a topical hemostatic agent for uncontrolled and noncompressible hemorrhage.
Copyright © 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Active and passive hemostasis; Hemostatic sponge; Rapid shape recovery; Thrombin-receptor-agonist-peptide

Year:  2019        PMID: 31449930     DOI: 10.1016/j.actbio.2019.08.039

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  4 in total

1.  Rapid Hemostatic Biomaterial from a Natural Bath Sponge Skeleton.

Authors:  Qinghua Wang; Jingwei Chen; Dexiang Wang; Minghui Shen; Huilong Ou; Jing Zhao; Ming Chen; Guoliang Yan; Jun Chen
Journal:  Mar Drugs       Date:  2021-04-15       Impact factor: 5.118

2.  Magnetic field-mediated Janus particles with sustained driving capability for severe bleeding control in perforating and inflected wounds.

Authors:  Qing Li; Enling Hu; Kun Yu; Mengxing Lu; Ruiqi Xie; Fei Lu; Bitao Lu; Rong Bao; Guangqian Lan
Journal:  Bioact Mater       Date:  2021-05-18

3.  Microchannelled alkylated chitosan sponge to treat noncompressible hemorrhages and facilitate wound healing.

Authors:  Xinchen Du; Le Wu; Hongyu Yan; Zhuyan Jiang; Shilin Li; Wen Li; Yanli Bai; Hongjun Wang; Zhaojun Cheng; Deling Kong; Lianyong Wang; Meifeng Zhu
Journal:  Nat Commun       Date:  2021-08-05       Impact factor: 14.919

Review 4.  Polymeric Materials for Hemostatic Wound Healing.

Authors:  Suvash Ghimire; Pritha Sarkar; Kasey Rigby; Aditya Maan; Santanu Mukherjee; Kaitlyn E Crawford; Kausik Mukhopadhyay
Journal:  Pharmaceutics       Date:  2021-12-09       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.